News

Latest

Aug 19, 2019 by Brian Gragnolati
When invited to play a larger role in their own care, many patients welcome the chance — and results show that patient engagement, in turn, improves outcomes.
Aug 15, 2019
Thirteen states yesterday filed a lawsuit challenging a Department of Homeland Security final rule limiting the ability of legal immigrants to adjust or extend their immigration status or gain full citizenship based on their prospective receipt of public benefits.
Aug 15, 2019
Beginning with open enrollment for plan year 2020, the Centers for Medicare & Medicaid Services will require all health insurance exchanges to display its star rating for each qualified health plan.
Aug 15, 2019
Currently available public hospital quality rating systems frequently offer conflicting results, which may mislead stakeholders relying on the ratings to identify top-performing hospitals.
Aug 15, 2019
The Oregon Association of Hospitals and Health Systems today named as its next president and CEO Becky Hultberg, who currently serves as president and CEO of the Alaska State Hospital and Nursing Home Association.
Aug 14, 2019
The U.S. Court of Appeals for the District of Columbia Circuit reversed the voiding of a rule that included Medicare and private insurance payments when calculating the hospital-specific limit on Medicaid disproportionate share hospital payments.
Aug 14, 2019
The U.S. Preventative Services Task Force yesterday released for comment a draft recommendation that primary care clinicians screen all adults for illicit drug use, including nonmedical prescription drug use.
Aug 14, 2019
The Centers for Disease Control and Prevention has released the first in a new series of free online training courses to help health care organizations prevent and control infections.
Aug 13, 2019
The AHA today urged the Department of Health and Human Services not to finalize certain proposed revisions to a 2016 final rule implementing the Affordable Care Act’s nondiscrimination protections for patients.
Aug 13, 2019
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those receiving two other treatments as part of the clinical trial.